KDs are not indicated in some clinical conditions including pregnancy and breastfeeding, chronic renal disease, use of sodium/glucose cotransporter 2 (SGLT2) inhibitors (risk of euglycemic diabetic ketoacidosis) and unstable angina [90,119]. Here, SLC5A2 is linked to angina unstable.